Noel R. Wallace Colgate Palmolive CO (CL) insider trading activity

Noel R. Wallace is Chairman, President & CEO of COLGATE PALMOLIVE CO. Currently has a direct ownership of 303,809 shares of CL, which is worth approximately $28.4 Million. The most recent transaction as insider was on Sep 13, 2024, when has been sold 4,039 shares (Common Stock) at a price of $105.73 per share, resulting in proceeds of $427,043. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 304K

5.9% 3M change

10.43% 12M change

Total Value Held $28.4 Million

Noel R. Wallace Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 13 2024	SELL Payment of exercise price or tax liability	$427,043 $105.73 p/Share	4,039 Reduced 1.31%	303,809 Common Stock
Sep 12 2024	BUY Grant, award, or other acquisition	-	20,689 Added 6.3%	307,848 Common Stock
Feb 20 2024	SELL Open market or private sale	$5,895,916 $84.29 p/Share	69,948 Reduced 19.6%	286,881 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	$3,781,925 $68.16 p/Share	55,486 Added 13.46%	356,829 Common Stock
Feb 16 2024	SELL Open market or private sale	$2,502,634 $84.06 p/Share	29,772 Reduced 8.99%	301,343 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	56,616 Added 14.6%	331,115 Common Stock
Feb 12 2024	SELL Open market or private sale	$4,157,500 $83.15 p/Share	50,000 Reduced 15.42%	274,179 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	$3,408,000 $68.16 p/Share	50,000 Added 13.36%	324,179 Common Stock
Dec 06 2023	SELL Payment of exercise price or tax liability	$100,633 $77.47 p/Share	1,299 Reduced 0.47%	274,179 Common Stock
Sep 13 2023	BUY Grant, award, or other acquisition	-	28,148 Added 9.28%	275,117 Common Stock
Sep 11 2023	SELL Open market or private sale	$3,567,762 $73.37 p/Share	48,627 Reduced 16.45%	246,969 Common Stock
Sep 11 2023	BUY Exercise of conversion of derivative security	$3,549,771 $73.0 p/Share	48,627 Added 14.13%	295,596 Common Stock
May 08 2023	SELL Open market or private sale	$4,033,000 $80.66 p/Share	50,000 Reduced 16.86%	246,619 Common Stock
May 08 2023	BUY Exercise of conversion of derivative security	$3,650,000 $73.0 p/Share	50,000 Added 14.43%	296,619 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$1,538,794 $72.77 p/Share	21,146 Reduced 7.9%	246,619 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	45,461 Added 14.51%	267,765 Common Stock
Aug 04 2022	SELL Open market or private sale	$4,198,814 $81.27 p/Share	51,665 Reduced 18.89%	221,790 Common Stock
Aug 04 2022	BUY Exercise of conversion of derivative security	$3,771,028 $72.99 p/Share	51,665 Added 15.89%	273,455 Common Stock
Jun 06 2022	SELL Open market or private sale	$3,967,000 $79.34 p/Share	50,000 Reduced 18.4%	221,790 Common Stock
Jun 06 2022	BUY Exercise of conversion of derivative security	$3,649,500 $72.99 p/Share	50,000 Added 15.54%	271,790 Common Stock
Feb 18 2022	SELL Open market or private sale	$3,060,789 $79.33 p/Share	38,583 Reduced 14.83%	221,625 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	73,562 Added 22.04%	260,208 Common Stock
Dec 08 2021	SELL Payment of exercise price or tax liability	$106,920 $77.76 p/Share	1,375 Reduced 0.57%	238,489 Common Stock
Nov 05 2021	SELL Open market or private sale	$7,740,000 $77.4 p/Share	100,000 Reduced 29.44%	239,699 Common Stock
Nov 05 2021	BUY Exercise of conversion of derivative security	$6,898,000 $68.98 p/Share	100,000 Added 22.74%	339,699 Common Stock

NRW

Noel R. Wallace

Chairman, President & CEO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CL shares.

Notify only if

Value

Insider Trading

Get notified when an Colgate Palmolive CO insider buys or sells CL shares.

Notify only if

Operation

Value

Type

News

Receive news related to COLGATE PALMOLIVE CO

Track Activities on CL

Account